Keith A. Goldan
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Keith A. Goldan
Keith A. Goldan is recorded as Board Member at Abeona Therapeutics Inc. (ABEO). Abeona Therapeutics Inc. reported in an 8-K filed April 7, 2026 that Keith A. Goldan was appointed Chair of the Audit Committee, effective April 1, 2026. Abeona Therapeutics Inc. reported in an 8-K filed April 7, 2026 that Keith A. Goldan was appointed member of the Board of the Company as a Class 1 director, effective April 1, 2026.
“The Board also appointed Mr. Goldan to serve as Chair of the Audit Committee.”
“On April 1, 2026, the Board of Directors (the "Board") of Abeona Therapeutics Inc. (the "Company"), acting upon the recommendation of its Nominating and Corporate Governance Committee, expanded the size of the Board from nine to ten members and appointed Keith A. Goldan as a member of the Board of the Company as a Class 1 director.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Abeona Therapeutics Inc. (ABEO)
SEC 8-K
Current2026-04-01–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Abeona Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Michael Amoroso CEO, Chairman, COO, Board Member
- Vishwas Seshadri CEO, Board Member
- Brian J.G. Pereira Chairman, Board Member
- Edward Carr CFO
- Joseph Vazzano CFO
- Brendan O’Malley General Counsel
- Bernhardt G. Zeiher Board Member
- Christine Berni Silverstein Board Member
- Christine Silverstein Board Member
- Donald A. Wuchterl Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.